Cognitive Effects of Prenatal Exposure to SSRIs in Children: A Systematic Review and Meta‐Analysis
International Journal of Pediatrics · 2026-01 · 2026 (1)
DOI: 10.1155/ijpe/7930070 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Pediatrics, online erschienen am 10.08.2026. Verfasst von Fatima Shafiya Ali und 8 weiteren Autor:innen. Beteiligte Einrichtung: General Medicine Practice, Batterjee Medical College, Jeddah, Saudi Arabia, bmc.edu.sa. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Depression and anxiety occur in about 10% of pregnancies. Selective serotonin reuptake inhibitors (SSRIs) are often prescribed, but their potential effects on fetal neurodevelopment remain uncertain. Because serotonin influences brain maturation, prenatal SSRI exposure may affect later cognition, language, or motor function.
Methods
This systematic review and meta‐analysis evaluated whether prenatal SSRI exposure is associated with differences in child cognitive, language, or psychomotor development. PubMed and Scopus were searched through June 2025 for cohort, case‐control, or randomized studies reporting standardized neurodevelopmental outcomes in children (0–18 years) with documented in utero SSRI exposure compared with unexposed controls. Two reviewers independently screened studies, extracted data, and assessed bias (Newcastle–Ottawa Scale; RoB‐2). Random‐effects meta‐analyses estimated standardized mean differences (SMDs) with 95% confidence intervals (CIs).
Results
Of 250 records identified, 17 studies met inclusion criteria, and 9 contributed to meta‐analysis. For general cognition, pooled SMD = −0.20 (95% CI −0.50 to 0.10) showed no significant difference between groups. Sensitivity analyses restricted to SSRI‐only cohorts and Bayley‐specific instruments yielded similar findings. Secondary outcomes also showed no differences: receptive language (SMD = 0.04; 95% CI −0.16 to 0.23), expressive language (SMD = −0.17; 95% CI −0.40 to 0.06), and psychomotor development (SMD = −0.18; 95% CI −0.67 to 0.31).
Conclusions
Current evidence does not support a clinically meaningful impact of prenatal SSRI exposure on early cognitive, language, or psychomotor development. Observed effects were small, imprecise, and diminished when analyses were limited to SSRI‐only cohorts and harmonized outcome measures.
Autor:innen und Institutionen
- General Medicine Practice, Batterjee Medical College, Jeddah, Saudi Arabia, bmc.edu.sa.
- School of Medicine, Lincoln American University, Georgetown, Guyana.
ORCID-Profile: Fatima Shafiya Ali, Huda Fatima, Zainab Jasim Alqurain, Aroob Abdullah Takruni, Sana Hashim, Aya Sami Dahroug, Husna Irfan Thalib, Shyma Haidar, Mable Pereira
Zitieren
APA
Ali, F. S., Fatima, H., Alqurain, Z. J., Takruni, A. A., Hashim, S., Dahroug, A. S., Thalib, H. I., Haidar, S., & Pereira, M. (2026). Cognitive Effects of Prenatal Exposure to SSRIs in Children: A Systematic Review and Meta‐Analysis. International Journal of Pediatrics, 2026(1). https://doi.org/10.1155/ijpe/7930070
Vancouver
Ali FS, Fatima H, Alqurain ZJ, Takruni AA, Hashim S, Dahroug AS, et al. Cognitive Effects of Prenatal Exposure to SSRIs in Children: A Systematic Review and Meta‐Analysis. International Journal of Pediatrics. 2026;2026(1). doi:10.1155/ijpe/7930070
BibTeX
@article{Ali2026,
author = {Ali, Fatima Shafiya and Fatima, Huda and Alqurain, Zainab Jasim and Takruni, Aroob Abdullah and Hashim, Sana and Dahroug, Aya Sami and Thalib, Husna Irfan and Haidar, Shyma and Pereira, Mable},
title = {Cognitive Effects of Prenatal Exposure to SSRIs in Children: A Systematic Review and Meta‐Analysis},
journal = {International Journal of Pediatrics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijpe/7930070}
}
EUVIMED